Business
Press Release Jul 23 2024
Gland Pharma Limited has informed the Exchange regarding a press release dated July 23, 2024, titled "Gland Pharma receives Tentative Approval from the USFDA for Latanoprostene Bunod Ophthalmic Solution ".
About this update from Gland Pharma Ltd.
[{"type":"text","content":" Gland Pharma Limited has informed the Exchange regarding a press release dated July 23, 2024, titled \"Gland Pharma receives Tentative Approval from the USFDA for Latanoprostene Bunod Ophthalmic Solution \". View Attachment","length":358,"tagName":"div"}]